The Utility of Plasma Vascular Biomarkers in Systemic Sclerosis: A Prospective Longitudinal Analysis.
Christopher A MecoliAmi A ShahFrancesco BoinFredrick M WigleyLaura K HummersPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2020)
These data suggest that molecules involved in angiogenesis reflect vascular perturbation, and that elevations in these biomarkers at first encounter can indicate patients who are at risk of PH development.